Guía de práctica clínica para la Profilaxis quirúrgica antimicrobiana
Barra lateral del artículo
Contenido principal del artículo
Resumen
La infección del sitio quirúrgico (ISQ) es una de las principales causas de infecciones asociadas a la atención en salud (IAAS), con un impacto significativo en la mortalidad y morbilidad del paciente quirúrgico, así como en los costos asociados a la atención en salud. El adecuado uso de la profilaxis quirúrgica antimicrobiana es un aspecto fundamental en la reducción del riesgo de ISQ, dado que su utilización inapropiada o indiscriminada puede representar un riesgo para los pacientes y contribuir al desarrollo de resistencia a los antimicrobianos, por lo que resulta de importancia generar directrices que permitan orientar el uso adecuado de antimicrobianos en la profilaxis del paciente quirúrgico, con el objetivo de obtener mejores desenlaces clínicos y propender por un uso racional de antibióticos. La presente guía contiene recomendaciones para profilaxis antibiótica de pacientes sometidos a procedimiento quirúrgico, basadas en la evidencia, realizadas mediante el proceso de adaptación de guías de práctica clínica para el contexto colombiano.
Detalles del artículo
Citas
Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13(10):606-8.
https://doi.org/10.2307/30148464
Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F, et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect. 2006;64(1):16-22.
https://doi.org/10.1016/j.jhin.2006.04.017
Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS. Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis. 2001;33 Suppl 2:S69-77.
https://doi.org/10.1086/321860
Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228-41.
https://doi.org/10.1016/S0140-6736(10)61458-4
Alvarez-Moreno C, Perez-Fernandez AM, Rosenthal VD, Quintero J, Chapeta-Parada E, Linares C, et al. Surgical site infection rates in 4 cities in Colombia: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2014;42(10):1089-92.
https://doi.org/10.1016/j.ajic.2014.06.010
Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008;70 Suppl 2:3-10.
https://doi.org/10.1016/S0195-6701(08)60017-1
Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017;96(1):1-15.
https://doi.org/10.1016/j.jhin.2017.03.004
Monahan M, Jowett S, Pinkney T, Brocklehurst P, Morton DG, Abdali Z, et al. Surgical site infection and costs in low- and middle-income countries: A systematic review of the economic burden. PLoS One. 2020;15(6):e0232960.
https://doi.org/10.1371/journal.pone.0232960
Astagneau P, Rioux C, Golliot F, Brucker G, Group INS. Morbidity and mortality associated with surgical site infections: results from the 1997- 1999 INCISO surveillance. J Hosp Infect. 2001;48(4):267-74.
https://doi.org/10.1053/jhin.2001.1003
Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20(11):725-30.
https://doi.org/10.1086/501572
Saavedra CH, Ordonez KM, Diaz JA. [Nosocomial infections impact in a hospital in Bogota, Colombia: effects on mortality and hospital costs]. Rev Chilena Infectol. 2015;32(1):25-9.
https://doi.org/10.4067/S0716-10182015000200004
WHO Guidelines for Safe Surgery 2009: Safe Surgery Saves Lives. WHO Guidelines Approved by the Guidelines Review Committee. Geneva2009.
U.S. Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN). Patient Safety Component Manual 2021.
Li X, Nylander W, Smith T, Han S, Gunnar W. Risk Factors and Predictive Model Development of Thirty-Day Post-Operative Surgical Site Infection in the Veterans Administration Surgical Population. Surg Infect (Larchmt). 2018;19(3):278-85.
https://doi.org/10.1089/sur.2017.283
Cheadle WG. Risk factors for surgical site infection. Surg Infect (Larchmt).2006;7 Suppl 1:S7-11.
https://doi.org/10.1089/sur.2006.7.s1-7
Anderson DJ, Podgorny K, Berrios-Torres SI, Bratzler DW, Dellinger EP, Greene L, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(6):605-27.
https://doi.org/10.1086/676022
Implementation manual to support the prevention of surgical site infections at the facility level - turning recommendations into practice (interim version). Geneva: World Health Organization; 2018 (WHO/HIS/SDS/2018.18).
Bull AL, Worth LJ, Spelman T, Richards MJ. Antibiotic Prescribing Practices for Prevention of Surgical Site Infections in Australia: Increased Uptake of National Guidelines after Surveillance and Reporting and Impact on Infection Rates. Surg Infect (Larchmt). 2017;18(7):834-40.
https://doi.org/10.1089/sur.2017.119
Vicentini C, Politano G, Corcione S, Furmenti MF, Quattrocolo F, De Rosa FG, et al. Surgical antimicrobial prophylaxis prescribing practices and impact on infection risk: Results from a multicenter surveillance study in Italy (2012-2017). Am J Infect Control. 2019;47(12):1426-30.
https://doi.org/10.1016/j.ajic.2019.07.013
Tiri B, Bruzzone P, Priante G, Sensi E, Costantini M, Vernelli C, et al. Impact of Antimicrobial Stewardship Interventions on Appropriateness of Surgical Antibiotic Prophylaxis: How to Improve. Antibiotics (Basel). 2020;9(4).
https://doi.org/10.3390/antibiotics9040168
World Health Organization. Antimicrobial resistance: global report on surveillance. World Health Organization, 2014.
Colombia. Ministerio de Salud y Protección Social. Guía Metodológica, Adopción Adaptación de Guías de Práctica Clínica Basadas en Evidencia. Guía metodológica en Internet. Edición 1ª. Bogotá DC. 2017, Disponible en gpc.minsalud.gov.co.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839-42.
https://doi.org/10.1503/cmaj.090449
Global guidelines for the prevention of surgical site infection, second edition. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
Berrios-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152(8):784-91.
https://doi.org/10.1001/jamasurg.2017.0904
Schunemann HJ, Wiercioch W, Brozek J, Etxeandia-Ikobaltzeta I, Mustafa RA, Manja V, et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol. 2017;81:101-10.
https://doi.org/10.1016/j.jclinepi.2016.09.009
Schunemann HJ, Mustafa R, Brozek J, Santesso N, Alonso-Coello P, Guyatt G, et al. GRADE Guidelines: 16. GRADE evidence to decisión frameworks for tests in clinical practice and public health. J Clin Epidemiol. 2016;76:89-98.
https://doi.org/10.1016/j.jclinepi.2016.01.032
Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-6.
https://doi.org/10.1016/j.jclinepi.2010.07.015
Ho VP, Barie PS, Stein SL, Trencheva K, Milsom JW, Lee SW, et al. Antibiotic regimen and the timing of prophylaxis are important for reducing surgical site infection after elective abdominal colorectal surgery. Surg Infect (Larchmt). 2011;12(4):255-60.
https://doi.org/10.1089/sur.2010.073
Steinberg JP, Braun BI, Hellinger WC, Kusek L, Bozikis MR, Bush AJ, et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg. 2009;250(1):10-6.
https://doi.org/10.1097/SLA.0b013e3181ad5fca
Onufrak NJ, Forrest A, Gonzalez D. Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing. Clin Ther. 2016;38(9):1930-47.
https://doi.org/10.1016/j.clinthera.2016.06.015
Markantonis SL, Kostopanagiotou G, Panidis D, Smirniotis V, Voros D. Effects of blood loss and fluid volume replacement on serum and tissue gentamicin concentrations during colorectal surgery. Clin Ther. 2004;26(2):271-81.
https://doi.org/10.1016/S0149-2918(04)90025-2
Zanetti G, Giardina R, Platt R. Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis. 2001;7(5):828-31.
https://doi.org/10.3201/eid0705.017509
Lanckohr C, Horn D, Voeller S, Hempel G, Fobker M, Welp H, et al. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery. J Thorac Cardiovasc Surg. 2016;152(2):603-10.
https://doi.org/10.1016/j.jtcvs.2016.04.024
WHO Global Guidelines for the Prevention of Surgical Site Infection Web Appendix 5 Summary of a systematic review on optimal timing for preoperative surgical antibiotic prophylaxis. https://www.who.int/infection-prevention/publications/ssi-web-appendices/en/.
Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326(5):281-6.
https://doi.org/10.1056/NEJM199201303260501
Garey KW, Dao T, Chen H, Amrutkar P, Kumar N, Reiter M, et al. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. J Antimicrob Chemother. 2006;58(3):645-50.
https://doi.org/10.1093/jac/dkl279
Kasatpibal N, Norgaard M, Sorensen HT, Schonheyder HC, Jamulitrat S, Chongsuvivatwong V. Risk of surgical site infection and efficacy of antibiotic prophylaxis: a cohort study of appendectomy patients in Thailand. BMC Infect Dis. 2006;6:111.
https://doi.org/10.1186/1471-2334-6-111
Mackeen AD, Packard RE, Ota E, Berghella V, Baxter JK. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev. 2014(12):CD009516.
https://doi.org/10.1002/14651858.CD009516.pub2
Swoboda SM, Merz C, Kostuik J, Trentler B, Lipsett PA. Does intraoperative blood loss affect antibiotic serum and tissue concentrations? Arch Surg. 1996;131(11):1165-71; discussion 71-2.
https://doi.org/10.1001/archsurg.1996.01430230047009
Zelenitsky SA, Ariano RE, Harding GK, Silverman RE. Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother. 2002;46(9):3026-30.
https://doi.org/10.1128/AAC.46.9.3026-3030.2002
Buckley R, Hughes GN, Snodgrass T, Huchcroft SA. Perioperative cefazolin prophylaxis in hip fracture surgery. Can J Surg. 1990;33(2):122-7.
Danda AK, Wahab A, Narayanan V, Siddareddi A. Single-dose versus single-day antibiotic prophylaxis for orthognathic surgery: a prospective,
randomized, double-blind clinical study. J Oral Maxillofac Surg. 2010;68(2):344-6.
https://doi.org/10.1016/j.joms.2009.09.081
Imamura H, Kurokawa Y, Tsujinaka T, Inoue K, Kimura Y, Iijima S, et al. Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, noninferiority trial. Lancet Infect Dis. 2012;12(5):381-7.
https://doi.org/10.1016/S1473-3099(11)70370-X
Kobayashi M, Takesue Y, Kitagawa Y, Kusunoki M, Sumiyama Y. Antimicrobial prophylaxis and colon preparation for colorectal surgery: Results of a questionnaire survey of 721 certified institutions in Japan. Surg Today. 2011;41(10):1363-9.
https://doi.org/10.1007/s00595-010-4511-x
Nooyen SM, Overbeek BP, Brutel de la Riviere A, Storm AJ, Langemeyer JJ. Prospective randomised comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting. Eur J Clin Microbiol Infect Dis. 1994;13(12):1033-7.
https://doi.org/10.1007/BF02111823
Westen EH, Kolk PR, van Velzen CL, Unkels R, Mmuni NS, Hamisi AD, et al. Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial. Acta Obstet Gynecol Scand. 2015;94(1):43-9.
https://doi.org/10.1111/aogs.12517
Mui LM, Ng CS, Wong SK, Lam YH, Fung TM, Fok KL, et al. Optimum duration of prophylactic antibiotics in acute non-perforated appendicitis. ANZ J Surg. 2005;75(6):425-8.
https://doi.org/10.1111/j.1445-2197.2005.03397.x
Balch A, Wendelboe AM, Vesely SK, Bratzler DW. Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile. PLoS One. 2017;12(6):e0179117.
https://doi.org/10.1371/journal.pone.0179117
Branch-Elliman W, O'Brien W, Strymish J, Itani K, Wyatt C, Gupta K. Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events. JAMA Surg. 2019;154(7):590-8.
https://doi.org/10.1001/jamasurg.2019.0569
Hall JC, Christiansen KJ, Goodman M, Lawrence-Brown M, Prendergast FJ, Rosenberg P, et al. Duration of antimicrobial prophylaxis in vascular surgery. Am J Surg. 1998;175(2):87-90.
https://doi.org/10.1016/S0002-9610(97)00270-5
Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR, Society of Thoracic S. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg. 2006;81(1):397-404.
https://doi.org/10.1016/j.athoracsur.2005.06.034
Berrios-Torres SI. Evidence-Based Update to the U.S. Centers for Disease Control and Prevention and Healthcare Infection Control Practices Advisory Committee Guideline for the Prevention of Surgical Site Infection: Developmental Process. Surg Infect (Larchmt). 2016;17(2):256-61.
https://doi.org/10.1089/sur.2015.264
Su HY, Ding DC, Chen DC, Lu MF, Liu JY, Chang FY. Prospective randomized comparison of single-dose versus 1-day cefazolin for prophylaxis in gynecologic surgery. Acta Obstet Gynecol Scand. 2005;84(4):384-9.
https://doi.org/10.1111/j.0001-6349.2005.00583.x
Bernard A, Pillet M, Goudet P, Viard H. Antibiotic prophylaxis in pulmonary surgery. A prospective randomized double-blind trial of flash cefuroxime versus forty-eight-hour cefuroxime. J Thorac Cardiovasc Surg. 1994;107(3):896-900.
https://doi.org/10.1016/S0022-5223(94)70347-7
Suzuki T, Sadahiro S, Maeda Y, Tanaka A, Okada K, Kamijo A. Optimal duration of prophylactic antibiotic administration for elective colon cancer surgery: A randomized, clinical trial. Surgery. 2011;149(2):171-8.
https://doi.org/10.1016/j.surg.2010.06.007
Hasselgren PO, Ivarsson L, Risberg B, Seeman T. Effects of prophylactic antibiotics in vascular surgery. A prospective, randomized, double-blind study. Ann Surg. 1984;200(1):86-92.
https://doi.org/10.1097/00000658-198407000-00016
Liu SA, Tung KC, Shiao JY, Chiu YT. Preliminary report of associated factors in wound infection after major head and neck neoplasm operations- -does the duration of prophylactic antibiotic matter? J Laryngol Otol. 2008;122(4):403-8.
https://doi.org/10.1017/S0022215107007529
Ali M, Raza A. Role of single dose antibiotic prophylaxis in clean orthopedic surgery. J Coll Physicians Surg Pak. 2006;16(1):45-8.
Garotta F, Pamparana F. Antimicrobial prophylaxis with ceftizoxime versus cefuroxime in orthopedic surgery. Ceftizoxime Orthopedic Surgery Italian Study Group. J Chemother. 1991;3 Suppl 2:34-5.
Zelenitsky SA, Silverman RE, Duckworth H, Harding GK. A prospective, randomized, double-blind studyof single high dose versus multiple standard dose gentamicin both in combination withmetronidazole for colorectal surgicalprophylaxis. J Hosp Infect. 2000;46(2):135-40.
https://doi.org/10.1053/jhin.2000.0814
Tamayo E, Gualis J, Florez S, Castrodeza J, Eiros Bouza JM, Alvarez FJ. Comparative study of single-dose and 24-hour multiple-dose antibiotic prophylaxis for cardiac surgery. J Thorac Cardiovasc Surg. 2008;136(6):1522-7.
https://doi.org/10.1016/j.jtcvs.2008.05.013
Lin MH, Pan SC, Wang JL, Hsu RB, Lin Wu FL, Chen YC, et al. Prospective randomized study of efficacy of 1-day versus 3-day antibiotic prophylaxis for preventing surgical site infection after coronary artery bypass graft. J Formos Med Assoc. 2011;110(10):619-26.
https://doi.org/10.1016/j.jfma.2011.08.003
Niederhauser U, Vogt M, Vogt P, Genoni M, Kunzli A, Turina MI. Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective? J Thorac Cardiovasc Surg. 1997;114(2):162-8.
https://doi.org/10.1016/S0022-5223(97)70140-5
Orlando G, Manzia TM, Sorge R, Iaria G, Angelico R, Sforza D, et al. One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial. Surgery. 2015;157(1):104-10.
https://doi.org/10.1016/j.surg.2014.06.007
Oxman DA, Issa NC, Marty FM, Patel A, Panizales CZ, Johnson NN, et al. Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial. JAMA Surg. 2013;148(5):440-6.
https://doi.org/10.1001/jamasurg.2013.1372
Clegg-Lamptey JN, Dakubo JC, Hodasi WM. Comparison of four-day and ten-day post-mastectomy passive drainage in Accra, Ghana. East Afr Med J. 2007;84(12):561-5.
https://doi.org/10.4314/eamj.v84i12.9592
Baas-Vrancken Peeters MJ, Kluit AB, Merkus JW, Breslau PJ. Short versus long-term postoperative drainage of the axilla after axillary lymph node dissection. A prospective randomized study. Breast Cancer Res Treat. 2005;93(3):271-5.
https://doi.org/10.1007/s10549-005-5348-7
WHO Surgical Site Infection Prevention Guidelines Web Appendix 27 Summary of a systematic review on antimicrobial prophylaxis in the presence of a drain and wound drain removal.
Konvalinka A, Errett L, Fong IW. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect. 2006;64(2):162-8.
https://doi.org/10.1016/j.jhin.2006.06.010
Fawley WN, Parnell P, Hall J, Wilcox MH. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin. J Hosp Infect. 2006;62(3):327-32.
https://doi.org/10.1016/j.jhin.2005.09.022
Hetem DJ, Bonten MJ. Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect. 2013;85(4):249-56.
https://doi.org/10.1016/j.jhin.2013.09.006
Bathoorn E, Hetem DJ, Alphenaar J, Kusters JG, Bonten MJ. Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use. J Clin Microbiol. 2012;50(9):2947-50.
https://doi.org/10.1128/JCM.00302-12
Lee AS, Macedo-Vinas M, Francois P, Renzi G, Schrenzel J, Vernaz N, et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis. 2011;52(12):1422-30.
https://doi.org/10.1093/cid/cir233
Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, Bogaers-Hofman D, de Baere GA, Stuurman A, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis. 2002;35(4):353 8.
https://doi.org/10.1086/341025
Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9-17.
https://doi.org/10.1056/NEJMoa0808939
Garcia AM, Villa MV, Escudero ME, Gomez P, Velez MM, Munera MI, et al. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections.] Biomedica. 2003;23:173-9.
https://doi.org/10.7705/biomedica.v23i2.1209
Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346(24):1871-7.
https://doi.org/10.1056/NEJMoa003069
Bediako-Bowan AAA, Molbak K, Kurtzhals JAL, Owusu E, Debrah S, Newman MJ. Risk factors for surgical site infections in abdominal surgeries in Ghana: emphasis on the impact of operating rooms door openings. Epidemiol Infect. 2020;148:e147.
https://doi.org/10.1017/S0950268820001454
Takahashi Y, Takesue Y, Fujiwara M, Tatsumi S, Ichiki K, Fujimoto J, et al. Risk factors for surgical site infection after major hepatobiliary and pancreatic surgery. J Infect Chemother. 2018;24(9):739-43.
https://doi.org/10.1016/j.jiac.2018.05.007
Morikane K. Epidemiology and risk factors associated with surgical site infection following surgery on thoracic aorta. Epidemiol Infect. 2018;146(14):1841-4.
https://doi.org/10.1017/S0950268818001930
Aga E, Keinan-Boker L, Eithan A, Mais T, Rabinovich A, Nassar F. Surgical site infections after abdominal surgery: incidence and risk factors. A prospective cohort study. Infect Dis (Lond). 2015;47(11):761-7.
https://doi.org/10.3109/23744235.2015.1055587
Matsui Y, Satoi S, Kaibori M, Toyokawa H, Yanagimoto H, Matsui K, et al. Antibiotic prophylaxis in laparoscopic cholecystectomy: a randomized controlled trial. PLoS One. 2014;9(9):e106702.
https://doi.org/10.1371/journal.pone.0106702
Orelio CC, van Hessen C, Sanchez-Manuel FJ, Aufenacker TJ, Scholten RJ. Antibiotic prophylaxis for prevention of postoperative wound infectionin adults undergoing open elective inguinal or femoral hernia repair. Cochrane Database Syst Rev. 2020;4:CD003769.
https://doi.org/10.1002/14651858.CD003769.pub5
Kirchhoff P, Hoffmann H, Köckerling F, Adolf D, Bittner R, Staerkle RF. Is antibiotic prophylaxis mandatory in laparoscopic incisional hernia repair? Data from the herniamed registry. Int J Surg. 2018 Oct;58:31-36.